St. Helier NHS Trust, U.K.

Study shows Botox has smaller spread beyond targeted area than Dysport

Published in Law and Health Weekly, August 26th, 2006

A pilot study designed to compare the migration characteristics of different formulations of botulinum toxin type A has demonstrated that Botox has a significantly smaller area of migration beyond the targeted area of injection compared to Dysport, a brand available in Europe but not approved for use in the U.S.

Different migration characteristics among botulinum toxin type A formulations may result in different tolerability profiles, according to the researchers.

"Our study reinforces the important fact that no two botulinum toxins are alike. Each behaves differently, physiologically and clinically, and each has a unique structure, formulation,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly

Source: Law and Health Weekly (2006-08-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry